Guided Therapeutics (GTHP) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026)
Guided Therapeutics (GTHP) Property, Plant & Equipment (Net) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 10.68% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 8.70% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 17.65% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 3.48% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 13.54% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 10.10% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -2.76% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 7.96% |
| 10 | Guided Therapeutics | 21.24 Mn | 21.23 Mn | - | -32.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -32.65% |
| Dec 31, 2025 | -27.51% |
| Sep 30, 2025 | -24.61% |
| Jun 30, 2025 | -26.32% |
| Mar 31, 2025 | -9.14% |
| Dec 31, 2024 | 18.00% |
| Sep 30, 2024 | 31.48% |
| Jun 30, 2024 | 58.74% |
| Mar 31, 2024 | 146.62% |
| Dec 31, 2023 | 217.48% |
| Sep 30, 2023 | 227.11% |
| Jun 30, 2023 | 230.19% |
| Mar 31, 2022 | 20.51% |
| Dec 31, 2021 | -12.64% |
| Sep 30, 2021 | -25.87% |
| Jun 30, 2021 | -39.75% |
| Mar 31, 2021 | -64.04% |
| Dec 31, 2020 | -72.67% |
| Sep 30, 2020 | -73.86% |
| Jun 30, 2020 | -75.13% |